Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America

2025, Press Releases

Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System,Ushering in a New Era of Modern Medicine Manufacturing in America Richmond, Virginia — April 22, 2025 — Phlow Corp., a leading pharmaceutical contract development and...

Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America

2025, Press Releases

Validation Completed for a Novel, Cost-Competitive Epinephrine Active Pharmaceutical Ingredient Process, Drug Master File Successfully Filed Richmond, Virginia, March 17, 2025 — Phlow Corp., a U.S.-based certified B Corporation on a mission to bring medicines to...

JPEO-CBRND, in Partnership with HHS, Utilizes Interagency Agreement to Contract with Phlow Corporation to Provide Medical Countermeasures

2024, Phlow™ in the News

FORT DETRICK, Md.  –  On August 13, 2024, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) participated in a kick-off meeting with Phlow Corporation at its facility in Petersburg, Virginia. This meeting marked...

Phlow Observes 4th Annual National Essential Medicine Shortage Awareness Day, Reaffirms Commitment to Protecting America’s Medicine Cabinet

2024, Corporate Statements

Reestablishing Pharmaceutical Sovereignty and Solving Our Nation’s Drug Shortage Crisis Richmond, Virginia, September 8, 2024 – Phlow announced today that it will honor the 4th National Essential Medicine Shortage Awareness Day (NEMSAD), a national observance day...

Drug Ingredient Builder Phlow Becomes Operational in Petersburg

2024, Phlow™ in the News

Phlow Corp.’s plant on Normandy Road is now operational, marking a significant milestone in Petersburg’s pharmaceutical manufacturing landscape. Read the article >